| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Project Lifecycle Processes - Phase 3 Delivery Phase |
|
Advice Pool - Project Lifecycle Processes - Phase 3 Delivery Phase
The purpose of the Delivery phase to design, develop, test, implement and hand o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ver the solution identified in Phase 2, the Feasibility Study Phase.
Key Players ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in > - The key players within the Delivery Phase are:
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. who is responsible for providing overall direction of the project and for ensur here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ng that periodic reviews or health checks are performed;
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ntative who is responsible for representing the Business Sponsor on day ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc -to-day matters and issues;
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ger who is responsible for managing this phase of the project, includin nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically controlling, monitoring, reviewing and reporting;
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ g>Stakeholders who are responsible for confirming the correct i ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nterpretation of the Users requirements;
Process Description & Recommendation ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ct Management Plan; cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin r and control the project; tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel 3 months, a review or health check is performed to:
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust in accordance with the corporate business objectives, and that it continues to meet a real busine y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ss need; . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de that forecasts of benefits to be delivered remain valid; elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ete and that the project team is adequately prepared to proceed to the next Phase; tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Is A Gas Opec A Real Threat To Europe? Let's Be Realistic About Nepotism: If You Hire Your Children Be Prepared For Criticism 9 Tips on Creating a Professional Emailed Job Application
|